» Articles » PMID: 34735658

Photobiomodulation Intervention Improves Oxidative, Inflammatory, and Morphological Parameters of Skeletal Muscle in Cirrhotic Wistar Rats

Overview
Journal Lasers Med Sci
Publisher Springer
Date 2021 Nov 4
PMID 34735658
Citations 2
Authors
Affiliations
Soon will be listed here.
Abstract

Photobiomodulation (PBM) might be an intervention method to mitigate sarcopenia in cirrhotic patients. Given the lack of research on this issue, the goal of this study was to evaluate possible beneficial effects of PBM on the structural and functional properties of skeletal muscle from cirrhotic rats. Cirrhosis was induced by secondary bile duct ligation (BDL). Wistar rats were randomized into four groups: sham-operated control (Sham), Sham + PBM, BDL, and BDL + PBM. After cirrhosis induction, a dose of PBM (1 J; 100mW; 10 s; 880 nm; 6 × per week) was applied to each quadriceps, from the 15th to the 45th day after surgery. The locomotor ability was performed using an open-field task. The muscle structure was analyzed using histological methods. Cell damage was also evaluated assessing oxidative stress and DNA damage markers, and IL-1β pro-inflammatory interleukin by immunohistochemical analysis. An increase in the number of crossings was observed in the BDL + PBM group in relation to BDL. The BDL group showed muscle atrophy and increased IL-1β in relation to Sham, while in the BDL + PBM group, the fiber muscle was restructured and there was a decrease of IL-1 β. TBARS increased in the liver and muscle tissues in the BDL group and decreased it in the BDL + PBM group. SOD increased while CAT decreased in the BDL + PBM group in relation to the BDL group. No genotoxic or mutagenic effect was observed for PBM treatment. PBM improved the locomotion and the morphology of the muscle fibers, decreasing oxidative stress and inflammation, without causing DNA damage in cirrhotic rats.

Citing Articles

Melatonin Attenuates Inflammation, Oxidative Stress, and DNA Damage in Mice with Nonalcoholic Steatohepatitis Induced by a Methionine- and Choline-Deficient Diet.

Miguel F, Picada J, Bondan da Silva J, Schemitt E, Raskopf Colares J, Minuzzo Hartmann R Inflammation. 2022; 45(5):1968-1984.

PMID: 35419738 DOI: 10.1007/s10753-022-01667-4.


Photobiomodulation Therapy Applied after 6 Months for the Management of a Severe Inferior Alveolar Nerve Injury.

El Mobadder M, Nammour S, Ortega M, Grzech-Lesniak K Life (Basel). 2021; 11(12).

PMID: 34947950 PMC: 8706621. DOI: 10.3390/life11121420.

References
1.
Moon A, Singal A, Tapper E . Contemporary Epidemiology of Chronic Liver Disease and Cirrhosis. Clin Gastroenterol Hepatol. 2019; 18(12):2650-2666. PMC: 7007353. DOI: 10.1016/j.cgh.2019.07.060. View

2.
Sinclair M, Gow P, Grossmann M, Angus P . Review article: sarcopenia in cirrhosis--aetiology, implications and potential therapeutic interventions. Aliment Pharmacol Ther. 2016; 43(7):765-77. DOI: 10.1111/apt.13549. View

3.
Ebadi M, Bhanji R, Mazurak V, Montano-Loza A . Sarcopenia in cirrhosis: from pathogenesis to interventions. J Gastroenterol. 2019; 54(10):845-859. PMC: 6759678. DOI: 10.1007/s00535-019-01605-6. View

4.
Duarte-Rojo A, Ruiz-Margain A, Montano-Loza A, Macias-Rodriguez R, Ferrando A, Kim W . Exercise and physical activity for patients with end-stage liver disease: Improving functional status and sarcopenia while on the transplant waiting list. Liver Transpl. 2017; 24(1):122-139. DOI: 10.1002/lt.24958. View

5.
Wijarnpreecha K, Werlang M, Panjawatanan P, Kroner P, Cheungpasitporn W, Lukens F . Association between sarcopenia and hepatic encephalopathy: A systematic review and meta-analysis. Ann Hepatol. 2019; 19(3):245-250. DOI: 10.1016/j.aohep.2019.06.007. View